Sankesh abbhi reports 9.04% stake in brainstorm cell therapeutics inc as of march 30 - sec filing

Sankesh abbhi reports 9.04% stake in brainstorm cell therapeutics inc as of march 30 - sec filing.sankesh abbhi reports 9.04% stake in brainstorm cell therapeutics inc as of march 30 - sec filing.
BCLI Ratings Summary
BCLI Quant Ranking